B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome
Open Access
- 6 June 2018
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2018, 1-5
Abstract
Antibody-mediated rejection (ABMR) of renal allograft lacks typical phenotypes and clinical manifestations, always resulting in delayed diagnosis and treatment. It has been considered to be an elemental factor influencing the improvement of the long-term outcome of renal allograft. The B cell activating factor (BAFF) signal plays a fundamental function in the process of antibody-mediated immune response. Data from recipients and the nonhuman primate ABMR model suggest that the BAFF signal participates in the ABMR of renal allograft, while there are objections. The challenges in the diagnosis of ABMR, different study population, and details of research may explain the discrepancy. Large quantities of dynamic, credible data of BAFF ligands and their association with renal allograft pathological characteristics would constitute a direct proof of the role of BAFF in the progression of renal allograft ABMR.Keywords
Funding Information
- National Science Foundation of Jiangsu Province (BK2011248, 81272367)
- National Natural Science Foundation of China (BK2011248, 81272367)
This publication has 39 references indexed in Scilit:
- B-cell activating factor BAFF reflects patients' immunological risk profile after kidney transplantationTransplant Immunology, 2017
- Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodiesKidney International, 2017
- Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney AllograftArchivum Immunologiae et Therapiae Experimentalis, 2016
- B-Cell–Activating Factor Levels Are Associated With Antibody-Mediated Histological Damage in Kidney TransplantationTransplantation Proceedings, 2016
- Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?Transplantation Proceedings, 2016
- BAFF receptors and ligands create independent homeostatic niches for B cell subsetsCurrent Opinion in Immunology, 2015
- Monitoring B cell subsets and alloreactivity in kidney transplantationTransplantation Reviews, 2015
- Elevated serum levels of B-cell activating factor in pediatric renal transplant patientsPediatric Nephrology, 2012
- Abnormal High Expression of B-Cell Activating Factor Belonging to the TNF Superfamily (BAFF) Associated With Long-Term Outcome in Kidney Transplant RecipientsTransplantation Proceedings, 2009
- The Expression of B-Cell Activating Factor Belonging to Tumor Necrosis Factor Superfamily (BAFF) Significantly Correlated With C4D in Kidney Allograft RejectionTransplantation Proceedings, 2009